Affymax, Takeda confirm US registration strategy for peginesatide - pharmabiz.com PDF Print
pharmabiz.com
"Our plan is to pursue approval of peginesatide for the treatment of anaemia in CRF patients on dialysis," said Arlene M. Morris, chief executive officer of

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.